Related references
Note: Only part of the references are listed.Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis
Kari J. Dugger et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Modern multiple sclerosis treatment - what is approved, what is on the horizon
Georg Pilz et al.
DRUG DISCOVERY TODAY (2008)
Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
Britta Engelhardt
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Natalizumab: Targeting alpha(4)-integrins in multiple sclerosis
Britta Engelhardt et al.
NEURODEGENERATIVE DISEASES (2008)
The immunopathology of multiple sclerosis:: An overview
Hans Lassmann et al.
BRAIN PATHOLOGY (2007)
Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis
Daniel C. Bullard et al.
JOURNAL OF IMMUNOLOGY (2007)
Escalating immunomodulatory therapy of multiple sclerosis.: Update (September 2006)
C. Bassetti et al.
NERVENARZT (2006)
The impact of interferon-β treatment on the blood-brain barrier
Joerg Kraus et al.
DRUG DISCOVERY TODAY (2006)
Natalizumab effects on immune cell responses in multiple sclerosis
M Niino et al.
ANNALS OF NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Immune surveillance of the human central nervous system (CNS): Different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons
TO Kleine et al.
CYTOMETRY PART A (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Interferon-β1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis
J Kraus et al.
JOURNAL OF NEUROLOGY (2004)
Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity
J Kraus et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
CD45RA+ ICAM-3+ lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis
J Kraus et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Share Paper
